- Citations, last 5 years
- 139
- Works, last 5 years
- 72
- h-index
- 40
- Scientists listed
- 12
- Grants since 2016
- 829
Grants received
2020–2023 · research · R01
Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease
Lutz Tautz · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Overriding the Immune Evasion Tactics of Coronavirus
Carl F Ware · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
A Pharmacochaperone-based strategy for identifying chemical probes of brain-derived orphan GPCRs
Michael Jackson · Discovery Institute · funded by National Institutes of Health
2020–2022 · research · R21
Modulation of metabolism in TILs by the checkpoint inhibitor PSGL-1
Linda Mac Pherson Bradley · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast Cancer
Brooke M Emerling · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast Cancer
Brooke M Emerling · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R01
The extrahepatopancreatic ducts as a novel source of hepatic progenitors
P. Duc Si Dong · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Non-Canonical Phosphatidylinositol Kinases in Triple Negative Breast Cancer
Brooke M Emerling · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R01
Identification of small molecule modulators of mitochondrial creatine kinase 1
Taro Hitosugi · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Overriding the Immune Evasion Tactics of Coronavirus
Carl F Ware · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
A Pharmacochaperone-based strategy for identifying chemical probes of brain-derived orphan GPCRs
Michael Jackson · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Defining chromostasis - a candidate regulator of healthy aging and longevity
Peter D. Adams · Discovery Institute · funded by National Institutes of Health
2020–2026 · research · R01
Role of Fbxw7-Mediated Proteasomal Degradation in Myofibers in Determining Muscle Stem Cell Pool Size
Pier Lorenzo Puri · Discovery Institute · funded by National Institutes of Health
2020–2022 · research · R21
Phenotypic Screening for Longevity Interventions Using Single-cell Epigenetic Signatures
Alexey V Terskikh · Discovery Institute · funded by National Institutes of Health
2020–2022 · career development · K99
A Role of Astrocyte and Microglia Interplay in Alzheimer's Disease
Lu-Lin Jiang · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
A Pharmacochaperone-based strategy for identifying chemical probes of brain-derived orphan GPCRs
Michael Jackson · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R01
The extrahepatopancreatic ducts as a novel source of hepatic progenitors
P. Duc Si Dong · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R01
Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease
Lutz Tautz · Discovery Institute · funded by National Institutes of Health
2020–2022 · research · R61
Optimization and Characterization of "MYC Degraders" for Pediatric Medulloblastoma
Michael Jackson · Discovery Institute · funded by National Institutes of Health
2020–2026 · research · R00
Spatial Regulators of Skeletal Muscle Regeneration and Disease
Yu Xin Wang · Discovery Institute · funded by National Institutes of Health
2020–2024 · research · R01
Development of STEP Allosteric Inhibitors as Novel Therapeutics for Alzheimer's Disease
Lutz Tautz · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Defining chromostasis - a candidate regulator of healthy aging and longevity
Peter D. Adams · Discovery Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction
Robert M Anthenelli · Discovery Institute · funded by National Institutes of Health
2020–2022 · career development · K99
A Role of Astrocyte and Microglia Interplay in Alzheimer's Disease
Lu-Lin Jiang · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Transformative research on somatic gene recombination in the normal and Alzheimer's disease-related dementia brain
Jerold Chun · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R01
The extrahepatopancreatic ducts as a novel source of hepatic progenitors
P. Duc Si Dong · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R01
Identification of small molecule modulators of mitochondrial creatine kinase 1
Taro Hitosugi · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Overriding the Immune Evasion Tactics of Coronavirus
Carl F Ware · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R21
The Macropinosome: Uncovering the Molecular Anatomy of an Oncogene-driven Organelle
Cosimo Commisso · Discovery Institute · funded by National Institutes of Health
2020–2023 · cooperative agreement · U01
Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction
Robert M Anthenelli · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
A Pharmacochaperone-based strategy for identifying chemical probes of brain-derived orphan GPCRs
Michael Jackson · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
Jerold Chun · Discovery Institute · funded by National Institutes of Health
2020–2025 · cooperative agreement · U01
Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction
Robert M Anthenelli · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Role of Fbxw7-Mediated Proteasomal Degradation in Myofibers in Determining Muscle Stem Cell Pool Size
Pier Lorenzo Puri · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
Jerold Chun · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R01
Discovery of Selective Inhibitors for the EphA4 Kinase
Elena B Pasquale · Discovery Institute · funded by National Institutes of Health
2020–2021 · research · R21
Targeting ERK5 for Colorectal Cancer Therapy
Garth Powis · Discovery Institute · funded by National Institutes of Health
2020–2023 · research · R01
Discovery of Selective Inhibitors for the EphA4 Kinase
Elena B Pasquale · Discovery Institute · funded by National Institutes of Health
2020–2025 · research · R01
Altered reverse transcriptase-dependent gene diversification mechanisms in Alzheimer's disease brains
Jerold Chun · Discovery Institute · funded by National Institutes of Health
2020–2022 · research · R21
Modulation of metabolism in TILs by the checkpoint inhibitor PSGL-1
Linda Mac Pherson Bradley · Discovery Institute · funded by National Institutes of Health